JPH0322370B2 - - Google Patents

Info

Publication number
JPH0322370B2
JPH0322370B2 JP55084627A JP8462780A JPH0322370B2 JP H0322370 B2 JPH0322370 B2 JP H0322370B2 JP 55084627 A JP55084627 A JP 55084627A JP 8462780 A JP8462780 A JP 8462780A JP H0322370 B2 JPH0322370 B2 JP H0322370B2
Authority
JP
Japan
Prior art keywords
herbal medicine
ultrafine
chinese herbal
hard capsules
concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55084627A
Other languages
Japanese (ja)
Other versions
JPS5711913A (en
Inventor
Yoshimasa Ichio
Hisahiro Uchida
Yoshihiko Akyama
Michio Nagasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsumura and Co
Original Assignee
Tsumura and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsumura and Co filed Critical Tsumura and Co
Priority to JP8462780A priority Critical patent/JPS5711913A/en
Publication of JPS5711913A publication Critical patent/JPS5711913A/en
Publication of JPH0322370B2 publication Critical patent/JPH0322370B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Description

【発明の詳細な説明】 本発明は内容物の崩壊性良好な漢方薬硬カプセ
ル剤の製法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing Chinese herbal medicine hard capsules whose contents have good disintegration properties.

近年、漢方薬が見直され、その需要は急増して
いる。しかるに、漢方薬はその薬臭、味が原因で
敬遠されがちである。この欠点を補う目的で種々
の工夫がなされているが、その1つとして硬カプ
セル剤とすることが考えられる。ところが、漢方
薬そのままを硬カプセルに詰めるのでは、その量
が多大となり、服用しずらい。又、漢方薬のエキ
スを粉末化して詰めると少量にはなるが、その硬
カプセル剤はその内容物の崩壊溶出に非常に長時
間を要するものとなり、医薬品として非常に好ま
しくない。つまり、漢方薬のエキスをそのまま粉
末化したものを硬カプセルに詰めて製した硬カプ
セル剤は、水に溶かそうとする時、その内容物で
ある漢方薬エキスの粉末は固まりを生じ、崩壊に
長時間を要する。これは、漢方薬エキスの粉末か
らなる内容物全体が、水にぬれてその表面に粘性
の強い膜を作り、この膜がそれ以上水が浸入する
のを妨げるからである。
In recent years, Chinese herbal medicine has been reconsidered, and demand for it is rapidly increasing. However, herbal medicines tend to be avoided due to their medicinal odor and taste. Various efforts have been made to compensate for this drawback, one of which is the use of hard capsules. However, if Chinese herbal medicines are packaged directly into hard capsules, the amount would be large, making it difficult to take. Furthermore, if the extract of a Chinese herbal medicine is powdered and packed, a small amount can be obtained, but the hard capsule requires a very long time for the contents to disintegrate and elute, making it extremely undesirable as a pharmaceutical product. In other words, when hard capsules are made by filling powdered Chinese herbal medicine extracts into hard capsules, when trying to dissolve them in water, the powdered Chinese herbal medicine extracts contained in the capsules clump together and take a long time to disintegrate. It takes. This is because the entire contents consisting of the Chinese herbal medicine extract powder get wet with water and form a highly viscous film on its surface, which prevents further water from penetrating.

本発明者等は、先にこの欠点を解決した、服用
し易く且つ内容物の崩壊性良好な漢方薬硬カプセ
ル剤の製法として、漢方薬の抽出液もしくはその
濃縮液に、超微粒子無水ケイ酸又は平均孔径が50
Å以上の多孔性無水ケイ酸を、該漢方薬の抽出液
もしくはその濃縮液の乾燥物に対して5〜100%
添加、分散させたものを噴霧乾燥して得た乾燥物
を、そのまま、あるいはいつたん圧縮成型した
後、破砕して粒または粉末として硬カプセルに詰
めることを特徴とする漢方薬硬カプセル剤の製法
を発明した(特開昭56−30914号)。
The present inventors previously solved this drawback by adding ultrafine silicic anhydride or average Pore diameter is 50
Porous silicic acid anhydride with a size of 5 to 100% based on the dried extract of the herbal medicine or its concentrate.
A process for producing hard capsules of Chinese herbal medicine, characterized in that the dried product obtained by spray-drying the added and dispersed product is compressed as it is or after compression molding, and then crushed and packed into hard capsules as granules or powder. (Japanese Patent Application Laid-Open No. 56-30914).

その後、本発明者等は、この製法に関し更に研
究を続けた結果、漢方薬の抽出液もしくはその濃
縮液に加える添加物としては、上記した超微粒子
無水ケイ酸のみならず、一般に水不溶性で無毒性
の超微粒子物であればよく、それを漢方薬の抽出
液もしくはその濃縮液に添加し噴霧乾燥して得た
乾燥物を用いて硬カプセル剤を製することによ
り、内容物の崩壊、溶出が極めて速かな漢方薬硬
カプセル剤を製造することがきることを見い出し
た。本発明はこの知見に基づくものである。
After that, the present inventors continued research on this manufacturing method, and found that not only the above-mentioned ultrafine silicic anhydride but also generally water-insoluble and non-toxic additives can be added to extracts or concentrates of Chinese herbal medicines. Ultrafine particles are sufficient, and by manufacturing hard capsules using the dried product obtained by adding it to the extract or concentrate of the Chinese herbal medicine and spray drying it, the disintegration and elution of the contents can be minimized. We have discovered that it is possible to quickly produce hard capsules of Chinese herbal medicine. The present invention is based on this knowledge.

即ち、本発明は、漢方薬の抽出液もしくはその
濃縮液に、超微粒子状酸化アルミニウム、超微粒
子状酸化チタン、合成ケイ酸アルミニウム、メタ
ケイ酸アルミン酸マグネシウムから選ばれる少な
くとも1種の超微粒子物を、該漢方薬の抽出液も
しくはその濃縮液の乾燥物に対して5〜100%添
加、分散させたものを噴霧乾燥して得た乾燥物
を、そのまま、あるいはいつたん圧縮成型した
後、破砕して粒または粉末として硬カプセルに詰
めることを特徴とする内容物の崩壊性良好な漢方
薬硬カプセル剤の製法であつて、内容物の崩壊、
溶出が極めて速かな、医薬品として必常に好まし
い漢方薬硬カプセル剤を得る方法を提供すること
を目的とするものである。
That is, the present invention adds at least one type of ultrafine particulate material selected from ultrafine particulate aluminum oxide, ultrafine particulate titanium oxide, synthetic aluminum silicate, and magnesium aluminate metasilicate to an extract of a Chinese herbal medicine or a concentrate thereof. The dried product obtained by spray-drying 5 to 100% addition and dispersion of the extract or concentrate of the Chinese herbal medicine to the dried product can be made into granules either directly or after compression molding. Or, a method for producing a Chinese herbal medicine hard capsule with good disintegration of the contents, characterized in that it is packed in a hard capsule as a powder, the disintegration of the contents, the disintegration of the contents,
The object of the present invention is to provide a method for obtaining hard capsules of Chinese herbal medicines, which are extremely fast in dissolution and are always preferred as pharmaceuticals.

以下、本発明について詳細に説明する。 The present invention will be explained in detail below.

本発明で用いる漢方薬には、漢方で言うところ
の漢方薬のみならず、生薬の1種又は2種以上の
混合物からなるいわゆる生薬もしくは生薬製剤も
包含される。
The herbal medicine used in the present invention includes not only herbal medicines referred to in Chinese medicine, but also so-called herbal medicines or herbal medicine preparations consisting of one or a mixture of two or more kinds of herbal medicines.

漢方薬の抽出液としては、常法通りに上記の漢
方薬を水で煎出又は浸出したもののみならず、ア
ルコールその他有機溶剤を用いて抽出したものも
用いることができる。
As the herbal medicine extract, not only those obtained by decocting or infusing the above-mentioned herbal medicines with water in a conventional manner, but also those extracted using alcohol or other organic solvents can be used.

本発明では、この漢方薬の抽出液又はこれを適
当な方法により濃縮した濃縮液に、超微粒子状酸
化アルミニウム、超微粒子状酸化チタン、合成ケ
イ酸アルミニウム、メタケイ酸アルミン酸マグネ
シウムから選ばれる少なくとも1種の平均粒子径
が数10mμの超微粒子物を添加、分散させる。
In the present invention, at least one member selected from ultrafine particulate aluminum oxide, ultrafine particulate titanium oxide, synthetic aluminum silicate, and magnesium aluminate metasilicate is added to the extract of this herbal medicine or a concentrate obtained by concentrating it by an appropriate method. Add and disperse ultrafine particles with an average particle size of several tens of microns.

この水不溶性で無毒性の超微粒子物としては、
超微粒子が凝集体をなすもの(好ましくは平均粒
子径が数10mμ以下の超微粒子が凝集体をなすも
の)で、それを漢方薬の抽出液もしくはその濃縮
液に添加し噴霧乾燥した際に、その凝集体の微粒
子間のすき間に漢方薬の成分を取り込むことがで
きるものであれば、何でも良い。その具体例とし
ては、例えば超微粒子状酸化アルミニウム、超微
粒子状酸化チタン、合成ケイ酸アルミニウム、メ
タケイ酸アルミン酸マグネシウム等を挙げること
ができる。
These water-insoluble, non-toxic ultrafine particles include:
It is an aggregate of ultrafine particles (preferably an aggregate of ultrafine particles with an average particle diameter of several tens of microns or less), and when it is added to a Chinese herbal medicine extract or its concentrate and spray-dried, the Any material may be used as long as it can incorporate the components of the herbal medicine into the gaps between the fine particles of the aggregate. Specific examples include ultrafine aluminum oxide, ultrafine titanium oxide, synthetic aluminum silicate, magnesium aluminate metasilicate, and the like.

そして上記超微粒子物は単独で又は2種以上を
混合して使用することができる。
The above-mentioned ultrafine particles can be used alone or in combination of two or more.

上記超微粒子物を添加し噴霧乾燥して得た漢方
薬の抽出液もしくはその濃縮液の乾燥物を用いて
硬カプセル剤を製造する時、そのカプセル剤の内
容物の崩壊が極めて速かになるのは、噴霧乾燥し
て生成する粒子の表面物性にこれら超微粒子物が
関与することによるものと考えられる。つまり、
漢方薬の抽出液もしくはその濃縮液に上記の不溶
性で無毒性の超微粒子物を添加して噴霧乾燥する
と、生成する噴霧乾燥粒子は内部が中空でその表
面は超微粒子物、即ち超微粒子が凝集した凝集体
の結合したものからなり、しかもこの凝集体の微
粒子間のすき間があたかも細孔のように働き、こ
のすき間に漢方薬の抽出液もしくはその濃縮液の
成分が入り込んだものとなり、このため、この噴
霧乾燥粒子を用いて製造した硬カプセル剤は、水
にぬれた際、その内容物が粘性の強い膜を作るこ
と無く、速やかに崩壊、分散するのであろうと推
測される。
When hard capsules are manufactured using dried Chinese herbal medicine extracts or concentrates obtained by adding the above-mentioned ultrafine particles and spray-drying, the contents of the capsules disintegrate extremely quickly. This is thought to be due to the involvement of these ultrafine particles in the surface properties of particles produced by spray drying. In other words,
When the above-mentioned insoluble, non-toxic ultrafine particles are added to a Chinese herbal medicine extract or its concentrate and spray-dried, the spray-dried particles that are formed are hollow inside and have ultrafine particles, that is, aggregated ultrafine particles, on the surface. It consists of a combination of aggregates, and the gaps between the fine particles of these aggregates act as if they were pores, and the components of the herbal medicine extract or its concentrate enter into these gaps. It is presumed that when hard capsules manufactured using spray-dried particles get wet with water, the contents will quickly disintegrate and disperse without forming a highly viscous film.

上記超微粒子物の添加量は、漢方薬の抽出液も
しくはその濃縮液の成分量との関係で決まり、漢
方薬の抽出液もしくはその濃縮液の乾燥物に対し
5〜100%が適当で、好ましくは10〜50%、最適
には15〜30%である。なお、上記超微粒子物の添
加量が少な過ぎれば当然の如く効果が現われない
訳であり、一方、多過ぎては服用カプセル量がそ
れだけ多くなることとなり好ましくない。かくし
て添加量はできるだけ必要最少限にするのが好適
であり、上記範囲の添加量が適当である。
The amount of the ultrafine particles added is determined in relation to the component amount of the herbal medicine extract or its concentrate, and is suitably 5 to 100%, preferably 10% to the dry matter of the herbal medicine extract or its concentrate. ~50%, optimally 15-30%. It should be noted that if the amount of the ultrafine particles added is too small, the effect will not be apparent, while if it is too large, the amount of capsules to be taken will increase accordingly, which is not preferable. Thus, it is preferable to keep the amount added to the minimum necessary amount, and an amount within the above range is appropriate.

上記超微粒子物を添加、分散させる手段は、上
記超微粒子物が漢方薬の抽出液もしくはその濃縮
液中に均一に分散できれば如何なる手段を用いて
もよく、例えば適当な撹拌装置を用いて行なうこ
とができる。
Any means may be used for adding and dispersing the ultrafine particles as long as the ultrafine particles can be uniformly dispersed in the extract of the Chinese herbal medicine or its concentrate. For example, an appropriate stirring device may be used. can.

上記のようにして、上記超微粒子物を添加、分
散させた漢方薬の抽出液またはその濃縮液の噴霧
乾燥はどの方式の噴霧乾燥機を用いて実施しても
よく、又、噴霧乾燥条件も常法通りに行えば良
い。例えば送風温度110〜200℃、排風温度90〜
160℃位で行なうことができる。
Spray-drying the herbal medicine extract or its concentrate to which the ultrafine particles have been added and dispersed as described above may be carried out using any type of spray dryer, and the spray-drying conditions may also be constant. Just follow the law. For example, the air temperature is 110~200℃, the exhaust temperature is 90~
It can be done at around 160℃.

上記のようにして得られた乾燥粉末は、そのま
ま硬カプセル例えばゼラチンなどのカプセルに詰
めても良いし、また適当な装置を用いていつたん
圧縮成型した後、破砕して粒または粉末としてか
ら硬カプセルに詰めても良い。又、硬カプセルへ
の充填に際しては賦形剤等の適当な添加物例えば
乳糖、微結晶セルロース、ステアリン酸マグネシ
ウムなどを添加してから詰めることもできる。
The dry powder obtained as described above may be directly packed into hard capsules, such as gelatin capsules, or it may be compression-molded using an appropriate device and then crushed to form granules or powder before being hardened. It can also be packed in capsules. Furthermore, when filling hard capsules, suitable additives such as excipients such as lactose, microcrystalline cellulose, magnesium stearate, etc. can be added before filling.

本発明により製造した漢方薬硬カプセル剤は、
その内容物の崩壊性が良好であり、溶解吸収性が
極めて優れたものである。又、副次的効果とし
て、充填物の変色、固化等の経時変化も起り難
く、医薬品として極めて好ましいものである。
The Chinese herbal medicine hard capsule prepared according to the present invention is
The contents have good disintegration properties and extremely excellent dissolution and absorption properties. In addition, as a side effect, changes over time such as discoloration and solidification of the filler are less likely to occur, making it extremely preferable as a pharmaceutical product.

以下、実施例を挙げて本発明をさらに具体的に
説明するが、本発明はこれにより制限されるもの
ではない。
EXAMPLES Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited thereto.

実施例 1 八味地黄丸(地黄6部、沢瀉3部、茯苓3部、
牡丹皮2.5部、桂枝1部、山薬3部、山茱〓3部、
加工ブシ0.5部より成る)の処方生薬5Kgを常法
通りに水50で煎じ、かすを去つた後、減圧下40
℃で約1/5に濃縮する。この液4(乾燥物800
g)を取り、超微粒子状酸化チタン〔「Titanium
OxideP25」(日本アエロジル株式会社製商品)
(超微粒子の平均粒子径約30mμ)〕を200g添加
し、プロペラ式撹拌機にて撹拌分散させる。この
液を噴霧乾燥(送風温度150℃、排風温度100℃)
して約900gの乾燥粉末を得た。この粉末をその
まま1号ゼラチンカプセルに充填(1カプセル中
480mg充填)して八味地黄丸の硬カプセル剤を得
た。
Example 1 Hachimijiogan (6 parts of Jianjiang, 3 parts of Sawatan, 3 parts of Bulyo,
2.5 parts of peony bark, 1 part of katsura, 3 parts of wild herbs, 3 parts of wild mushrooms,
Decoct 5 kg of prescribed herbal medicine (consisting of 0.5 parts of processed bush) with 50 kg of water in the usual manner, remove the residue, and boil under reduced pressure for 40 kg.
Concentrate to approximately 1/5 at °C. This liquid 4 (dry matter 800
g) and ultrafine particle titanium oxide [Titanium
OxideP25” (product manufactured by Nippon Aerosil Co., Ltd.)
(average particle size of ultrafine particles of approximately 30 mμ)] was added and stirred and dispersed using a propeller type stirrer. Spray dry this liquid (blow temperature 150℃, exhaust temperature 100℃)
About 900 g of dry powder was obtained. Fill this powder directly into No. 1 gelatin capsules (in 1 capsule
(480mg filling) to obtain hard capsules of Hachimijiogan.

ここに製造した八味地黄丸の硬カプセル剤は、
下記の崩壊試験では平均4.6分と極めて速かに崩
壊し、速かに成分を溶出した。これに対し、上記
超微粒子状酸化チタンを添加するかわりに、通常
の顔料用酸化チタン(平均粒子径0.5μ)を添加し
て上記と同様にして製造した八味地黄丸の硬カプ
セル剤の崩壊時間は11.6分であつた。又、上記超
微粒子状酸化チタンを添加しない以外は上記した
と同様にして製造した八味地黄丸の硬カプセル剤
の崩壊時間は平均13.5分であつた。
The hard capsules of Hachimijiogan manufactured here are
In the disintegration test described below, it disintegrated very quickly, taking an average of 4.6 minutes, and the components were quickly eluted. In contrast, instead of adding the ultrafine particulate titanium oxide, the hard capsules of Hachimijiogan, which were produced in the same manner as above by adding ordinary titanium oxide for pigments (average particle size 0.5μ), collapsed. The time was 11.6 minutes. Further, the disintegration time of hard capsules of Hachimijiogan produced in the same manner as described above except that the ultrafine particulate titanium oxide was not added was 13.5 minutes on average.

なお、崩壊時間は第9改正日本薬局方の崩壊試
験法にしたがつて測定した。即ち、内径22mmの両
端が開口したガラス管の下端を網目の開き2.0mm
の網でふさぎ、その網の上に試料のカプセル剤を
1ケ置き、このガラス管を試験液(塩化ナトリウ
ム2.0gに希塩酸24.0mlおよび水を加えて1000ml
としたPH約1.2の液)に浸けて上下させ網上に残
留物を認めなくなつた時を崩壊終了として崩壊時
間とした。なおまた、崩壊時間はそれぞれ6カプ
セルの平均崩壊時間で表わしたものである。
The disintegration time was measured according to the disintegration test method of the 9th edition of the Japanese Pharmacopoeia. In other words, the lower end of a glass tube with an inner diameter of 22 mm and open ends is
Place one capsule of the sample on the net, and add 1000 ml of the test solution (2.0 g of sodium chloride, 24.0 ml of diluted hydrochloric acid, and water) to the glass tube.
It was immersed in a liquid with a pH of approximately 1.2) and raised and lowered, and the time when no residue was observed on the screen was defined as the end of the collapse and the collapse time. Furthermore, each disintegration time is expressed as the average disintegration time of 6 capsules.

実施例 2 超微粒子状酸化チタンの代りに超微粒子状酸化
アルミニウム〔「Aluminium Oxide C(日本アエ
ロジル株式会社製商品)(超微粒子の平均粒子径
約20mμ)〕を用いる以外は、実施例1に記載した
と同様に実施して八味地黄丸の硬カプセル剤を得
た。
Example 2 The same as in Example 1 except that ultrafine aluminum oxide [Aluminum Oxide C (product manufactured by Nippon Aerosil Co., Ltd.) (average particle diameter of ultrafine particles approximately 20 mμ)] was used instead of ultrafine titanium oxide. Hard capsules of Hachimijiogan were obtained in the same manner as above.

この硬カプセル剤は、前述の崩壊試験では平均
4.0分で崩壊し、速かに成分を溶出した。これに
対し、上記超微粒子状酸化アルミニウムを添加し
ない以外は、上記したと同様にして製造した八味
地黄丸の硬カプセル剤の崩壊時間は前述したよう
に平均13.5分であつた。
This hard capsule has an average
It disintegrated in 4.0 minutes and the components were rapidly eluted. On the other hand, the disintegration time of hard capsules of Hachimijiogan produced in the same manner as above except that the ultrafine particulate aluminum oxide was not added was 13.5 minutes on average, as described above.

実施例 3 安中散(桂枝4部、延胡索3部、牡蠣3部、茴
香1.5部、縮砂1部、甘草1部、良姜0.5部)の処
方生薬5Kgを常法通りに水50に煎じ、かすを去
つた後、減圧下40℃で約1/5に濃縮する。この液
5(乾燥物750g)を取り、メタケイ酸アルミ
ン酸マグネシウム〔「ノイシリンUFL2」(富士化
学工業株式会社製商品)(超微粒子の平均粒子径
約20mμ)〕を250g添加し、撹拌分散させる。こ
の液を噴霧乾燥(送風温度160℃、排風温度110
℃)して約900gの乾燥粉末を得た。この粉末を
そのまま1号ゼラチンカプセルに充填(1カプセ
ル中430mg充填)して安中散の硬カプセル剤を得
た。
Example 3 5 kg of the prescription crude drug Annachusan (4 parts Katsura, 3 parts Enkosao, 3 parts Oyster, 1.5 parts Boka, 1 part Chisago, 1 part Licorice, 0.5 parts Ryojyo) was mixed with 50 kg of water as usual. After decoction and removing the residue, concentrate to about 1/5 at 40℃ under reduced pressure. Take this liquid 5 (750 g of dry matter), add 250 g of magnesium aluminate metasilicate ["Neusilin UFL 2 " (product manufactured by Fuji Chemical Industry Co., Ltd.) (average particle diameter of ultrafine particles about 20 mμ)], and stir and disperse. . Spray dry this liquid (blow temperature 160℃, exhaust temperature 110℃)
℃) to obtain about 900 g of dry powder. This powder was directly filled into No. 1 gelatin capsules (430 mg in each capsule) to obtain hard capsules of Annachusan.

ここに製造した安中散の硬カプセル剤は、前述
した崩壊試験では平均3.2分と極めて速かに崩壊
し、速かに成分を溶出した。これに対し、上記メ
タケイ酸アルミン酸マグネシウムを添加しない以
外は、上記したと同様にして製造した安中散の硬
カプセル剤の崩壊時間は平均17.8分であつた。
The hard capsules of Annachusan produced here disintegrated very quickly in the disintegration test described above, taking an average of 3.2 minutes, and the ingredients were rapidly eluted. On the other hand, the average disintegration time of hard capsules of Anchu-san produced in the same manner as described above except that the magnesium aluminate metasilicate was not added was 17.8 minutes.

実施例 4 大柴胡湯(柴胡6部、半夏4部、黄棗3部、芍
薬3部、大〓3部、枳実2部、乾生姜1部、大黄
1部)の処方生薬5Kg常法通りに水75で煎じ、
かすを去つた後、減圧下40℃で約1/6に濃縮する。
この液5(乾燥物800g)を取り、合成ケイ酸
アルミニウム〔「合成ケイ酸アルミニウム特軽質」
(協和化学工業株式会社製商品)(超微粒子の平均
粒子径約20mμ)〕300gを添加し、撹拌分散させ
る。以下、実施例1に記載したと同様に噴霧乾燥
し、1号ゼラチンカプセルに充填(1カプセル中
420mg充填)して大柴胡湯の硬カプセル剤を得た。
Example 4 Prescription of Daisaikoto (6 parts of Saiko, 4 parts of Hanxia, 3 parts of Ojutsu, 3 parts of Paeonia, 3 parts of Daio, 2 parts of Japanese betel, 1 part of dried ginger, 1 part of Rhubarb) 5Kg of conventional herbal medicines Stew in water 75%,
After removing the residue, concentrate to about 1/6 at 40°C under reduced pressure.
Take this liquid 5 (800 g of dry matter) and add synthetic aluminum silicate ["synthetic aluminum silicate special light"]
(Product manufactured by Kyowa Chemical Industry Co., Ltd.) (Average particle diameter of ultrafine particles approximately 20 mμ)] Add 300 g and stir and disperse. The following was spray-dried in the same manner as described in Example 1, and filled into No. 1 gelatin capsules (each capsule contained
(420mg filling) to obtain hard capsules of Daisaikoto.

ここに製造した大柴胡湯の硬カプセル剤は、前
述した崩壊試験で試験したところ、平均4.3分と
極めて速かに崩壊し、速かに成分を溶出した。こ
れに対し、上記合成ケイ酸アルミニウムを添加し
ない以外は、上記したと同様にして製造した大柴
胡湯の硬カプセル剤の崩壊時間は平均21.6分であ
つた。
When the hard capsules of Daisaikoto produced here were tested in the disintegration test described above, they disintegrated very quickly, taking an average of 4.3 minutes, and the ingredients were rapidly eluted. In contrast, the average disintegration time of the hard capsules of Daisaikoto produced in the same manner as described above except that the synthetic aluminum silicate was not added was 21.6 minutes.

実施例 5 薬用人参5Kgを常法通りに水50で煎じ、かす
を去つた後、減圧下40℃で約1/4に濃縮する。こ
の液4(乾燥物750g)を取り、実施例3に記
載したメタケイ酸アルミン酸マグネシウムを150
g添加し、撹拌分散させる。この液を噴霧乾燥
(送風温度160℃、排風温度105℃)して約800gの
乾燥粉末を得た。この粉末を乾式造粒機(バルク
コンパクター)にていつたん圧縮成型した後、破
砕して粉末とし、これに微結晶セルロース20%を
添加して1号ゼラチンカプセルに充填(1カプセ
ル中440mg充填)して薬用人参の硬カプセル剤を
得た。
Example 5 5kg of medicinal ginseng is decocted with 50% of water in a conventional manner, and after removing the residue, it is concentrated to about 1/4 at 40°C under reduced pressure. Take this liquid 4 (750 g of dry matter) and add 150 g of magnesium aluminate metasilicate described in Example 3.
g and stir to disperse. This liquid was spray-dried (blow temperature: 160°C, exhaust temperature: 105°C) to obtain about 800 g of dry powder. This powder is compressed and molded using a dry granulator (bulk compactor), then crushed to form a powder. 20% microcrystalline cellulose is added to this powder and packed into No. 1 gelatin capsules (440 mg in each capsule). Then, hard capsules of medicinal ginseng were obtained.

この硬カプセル剤は、前述の崩壊試験で試験し
たところ平均3.0分で崩壊し、速かに成分を溶出
した。これに対し、上記メタケイ酸アルミン酸マ
グネシウムを添加しない以外は、上記したと同様
にして製造した薬用人参の硬カプセル剤は、前述
した崩壊試験で試験したところ18.5分の崩壊時間
を要した。
When this hard capsule was tested in the disintegration test described above, it disintegrated in an average of 3.0 minutes, and the ingredients were rapidly eluted. On the other hand, hard capsules of medicinal ginseng produced in the same manner as described above except that the magnesium aluminate metasilicate was not added required a disintegration time of 18.5 minutes when tested in the disintegration test described above.

Claims (1)

【特許請求の範囲】[Claims] 1 漢方薬の抽出液もしくはその濃縮液に、超微
粒子状酸化アルミニウム、超微粒子状酸化チタ
ン、合成ケイ酸アルミニウム、メタケイ酸アルミ
ン酸マグネシウムから選ばれる少なくとも1種の
平均粒子径が数10mμの超微粒子物を、該漢方薬
の抽出液もしくはその濃縮液の乾燥物に対して5
〜100%添加、分散させたものを噴霧乾燥して得
た乾燥物を、そのまま、あるいはいつたん圧縮成
型した後、破砕して粒または粉末として硬カプセ
ルに詰めることを特徴とする内容物の崩壊性良好
な漢方薬硬カプセル剤の製法。
1 At least one ultrafine particle with an average particle diameter of several tens of mμ selected from ultrafine aluminum oxide, ultrafine titanium oxide, synthetic aluminum silicate, and magnesium aluminate metasilicate is added to the extract of Chinese herbal medicine or its concentrate. 5 for the dried extract of the Chinese herbal medicine or its concentrate.
The disintegration of the contents is characterized by spray-drying a 100% added and dispersed product, either as it is, or after compression molding, crushing it and filling it into hard capsules as granules or powder. A method for manufacturing Chinese herbal medicine hard capsules with good properties.
JP8462780A 1980-06-24 1980-06-24 Preparation of hard-capsule of herb medicine Granted JPS5711913A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8462780A JPS5711913A (en) 1980-06-24 1980-06-24 Preparation of hard-capsule of herb medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8462780A JPS5711913A (en) 1980-06-24 1980-06-24 Preparation of hard-capsule of herb medicine

Publications (2)

Publication Number Publication Date
JPS5711913A JPS5711913A (en) 1982-01-21
JPH0322370B2 true JPH0322370B2 (en) 1991-03-26

Family

ID=13835907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8462780A Granted JPS5711913A (en) 1980-06-24 1980-06-24 Preparation of hard-capsule of herb medicine

Country Status (1)

Country Link
JP (1) JPS5711913A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49110815A (en) * 1973-03-05 1974-10-22
JPS587608A (en) * 1981-07-08 1983-01-17 Hitachi Ltd Manufacture of color filter

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49110815A (en) * 1973-03-05 1974-10-22
JPS587608A (en) * 1981-07-08 1983-01-17 Hitachi Ltd Manufacture of color filter

Also Published As

Publication number Publication date
JPS5711913A (en) 1982-01-21

Similar Documents

Publication Publication Date Title
JP2552785B2 (en) Pharmaceutical composition that rapidly suspends in water
JPH11500441A (en) Use of inorganic aerogels in pharmacy
CN112353845B (en) Hot-melt extrusion composition containing traditional Chinese medicine volatile oil, preparation method thereof and pharmaceutical preparation
CN1082421A (en) Clear away heart-fire microencapsulation and manufacture method thereof
JP3269131B2 (en) Method for producing Chinese herbal hard capsules
CN1785336A (en) Tongyou dryness moistening fast dispersion solid preparation and its preparation method
KR100821248B1 (en) Granulated product and process for producing tablets
CN100488493C (en) Antelope horn fast dispersion solid preparation for clearing lung
JP6272432B2 (en) Granulated product containing Kamitsumonoyu extract powder
CN100398131C (en) Infant spleen-tonifying fast dispersion solid preparation and its preparation method
CN100515410C (en) Motherwort quick dispersion solid preparation and its preparation method
JPH0322370B2 (en)
JP5059678B2 (en) Colored solid preparation and method for producing the same
JPH0153254B2 (en)
JP4532903B2 (en) Fine particle composition
CN100515471C (en) Liver kidney nourishing fast dispersion solid preparation and its preparation method
CN106880611A (en) A kind of tolvaptan preparation of tolvaptan and water soluble adjuvant containing micronizing
JPS587608B2 (en) Manufacturing method for Chinese herbal medicine hard capsules
CN100384405C (en) Hepatitis B support right fast dispersion solid preparation and its preparation method
CN100364502C (en) Anemarrhena, phello dendron and rehmannia fast dispersion solid medicinal preparation and its manufacturing method
CN100428929C (en) Kunshun fast dispersion solid preparation and its preparation method
JP7219617B2 (en) Method for producing pharmaceutical composition containing fine particles of poorly soluble drug
Gohary et al. Release of furosemide from sustained release microcapsules prepared by phase separation technique
JPH0153253B2 (en)
JP3796848B2 (en) Herbal medicine-containing solid composition